HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Obstacles to adherence to azacitidine administration schedule in outpatient myelodysplastic syndrome and related disorders.

AuthorsAndrea Tendas, Maria Felicita Lissia, Daniela Piccioni, Liliana Tirimbelli, Laura Scaramucci, Marco Giovannini, Teresa Dentamaro, Alessio Perrotti, Paolo de Fabritiis, Pasquale Niscola
JournalSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (Support Care Cancer) Vol. 23 Issue 2 Pg. 303-5 (Feb 2015) ISSN: 1433-7339 [Electronic] Germany
PMID25370894 (Publication Type: Letter)
Chemical References
  • Antimetabolites, Antineoplastic
  • Azacitidine
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antimetabolites, Antineoplastic (therapeutic use)
  • Azacitidine (therapeutic use)
  • Drug Administration Schedule
  • Female
  • Humans
  • Male
  • Medication Adherence
  • Middle Aged
  • Myelodysplastic Syndromes (drug therapy)
  • Outpatients

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: